-

VideaHealth Announces Foundational Dental AI Patent Granted by U.S. Patent and Trademark Office (USPTO)

Patent design underpins today’s commercial dental image analysis AI platforms

BOSTON--(BUSINESS WIRE)--The U.S. Patent and Trademark Office (USPTO) has awarded VideaHealth, the trusted dental artificial intelligence (AI) platform, a patent for its dental AI image recognition technology.

In 2018, well before dental AI was commercially viable, Florian Hillen, CEO and founder of VideaHealth, designed the technology encapsulated in Patent no. 11,553,874. VideaHealth’s patent covers dental image feature detection powered by machine learning that helps dentists detect dental diseases on images and matches those findings to patient records. Hillen’s vision and early work act as the cornerstone of dental AI today as VideaHealth’s patent, at the most basic level, is the critical concept that drives today’s dental AI technologies.

“When I was still a researcher, I saw how impactful AI was becoming for everything from customer service applications to financial market use cases and to healthcare. It was then that I realized how powerful AI insights could be in dentistry when applied to X-ray analysis,” said Florian Hillen, CEO and founder of VideaHealth. “AI-powered X-ray analysis serves as a data-driven assistant to dentists, bringing a higher level of confidence to both dentists and patients. Having my early vision recognized by the USPTO is gratifying and reminds me of how far we have come since those early days.”

Since 2018, Hillen has designed and launched VideaHealth’s commercial dental AI platform, which contains FDA-cleared medical algorithms that improve disease detection and foster stronger patient communication.

VideaHealth’s AI Today, In Action

With a mission to improve the lives of millions of patients worldwide, VideaHealth continues to push the boundaries of what is possible in the dental industry. VideaHealth’s dental AI software platform, Videa Assist, delivers AI-powered X-ray analysis based on millions of data points to help dentists better identify patterns of disease and recognize areas that require further intraoral investigation.

The Benefit to Today’s Dentists

With AI adoption accelerating in dentistry, dentists can now leverage vast amounts of data to improve diagnostic abilities and treatment plan recommendations. With VideaHealth’s AI platform, there is next to no effort required from the dentist to gather these insights –they are directly integrated into the dentist’s workflow. As a result, dentists can deliver more individualized and efficient patient care effortlessly. Dentists using VideaHealth’s AI technology today are seeing increases in case acceptance rates, and patients are receiving an elevated standard of care as levels of understanding and trust are strengthened.

The company is working with industry partners like Henry Schein One and dental support organizations (DSOs) like 42 North to actively deploy its technology across the U.S. A provider of best-in-class customer support, the VideaHealth team guides change management processes to help clinicians and DSOs fully realize the benefits of diagnostic dental AI for accelerated practice growth and superior patient outcomes.

For more information, including images, charts and tables, please visit: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/11553874

About VideaHealth

VideaHealth is the dental AI platform trusted by the world's leading DSOs and dental clinicians. Rooted in AI research conducted at Harvard and MIT, VideaHealth’s FDA-cleared dental AI technology is clinically proven to improve diagnostic accuracy and treatment plans, enabling dentists to consistently deliver better patient care. Focused on driving clinical excellence, VideaHealth has the largest and most diverse data set in the market, which strengthens clinical decision-making abilities and patient relationships. Backed by leading venture capital firms Spark Capital, Zetta Venture Partners and Pillar VC, VideaHealth is headquartered in Boston. For more information, visit https://www.videa.ai.

Contacts

Aimee Bowen, Metis Communications
(910) 465-0634
videahealth@metiscomm.com

VideaHealth


Release Versions

Contacts

Aimee Bowen, Metis Communications
(910) 465-0634
videahealth@metiscomm.com

More News From VideaHealth

VideaHealth Secures FDA Clearance for Videa Dental Assist, Now Addressing Virtually All Common Dental Disease

BOSTON--(BUSINESS WIRE)--VideaHealth, the leading dental artificial intelligence (AI) platform, today announced the U.S. Food and Drug Administration (FDA) has issued 510(k) clearance for Videa Dental Assist, which includes more than 30 AI algorithms and expands AI detections to cover all of the most common dental diseases. Florian Hillen, CEO of VideaHealth, said, “This is one of the largest, most impactful FDA clearances in the history of healthcare and will elevate the patient care for the t...

Poll: More than 90% of Americans Know Dental Disease Can Increase Potential Risk for Disease, and Yet nearly 1 out of 2 Have Declined or Delayed Treatment

BOSTON--(BUSINESS WIRE)--VideaHealth, the leading dental AI software company, today announced the results of new research which found more than 90 percent (94%) of consumers surveyed agree that untreated oral issues, such as cavities and unhealthy gums, directly impact overall physical health and risk of disease, suggesting that public health campaigns designed to raise awareness of the long-term impact of oral disease on overall health are working. However, there is a gaping disconnect between...

Lumio Dental selects VideaAI to improve its patient experience while growing dental production

TULSA, Okla.--(BUSINESS WIRE)--Lumio Dental announced today that it has selected VideaHealth, the leading dental AI platform trusted by the most dental clinicians in the U.S., to improve its patient experience while increasing treatment production. Lumio Dental first deployed VideaHealth’s VideaAI in mid-2022 alongside several other dental AI solutions. After seeing outperforming results in terms of adoption, treatment acceptance, ROI and dental clinician feedback, the organization decided to e...
Back to Newsroom